148 results
8-K
EX-99.1
INBS
Intelligent Bio Solutions Inc
8 May 24
Intelligent Bio Solutions Inc. Reports Fiscal 2024 Third Quarter and Nine-Month Financial Results and Operational Highlights
4:30pm
receivable, net
Inventories, net
Research and development tax incentive receivable
Other current assets
Total current assets
Property and equipment, net …
Net loss attributable to non-controlling interest
Net loss attributable to Intelligent Bio Solutions Inc.
Other comprehensive income/(loss), net of tax
8-K
EX-4.1
INBS
Intelligent Bio Solutions Inc
12 Mar 24
Intelligent Bio Solutions Announces $10.1 Million Private Placement Priced At-the-Market Under Nasdaq Rules
8:30pm
without charge to the Holder for any issue or transfer tax or other incidental expense in respect of the issuance of such Warrant Shares, all … require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto. The Company shall pay all
8-K
EX-4.2
INBS
Intelligent Bio Solutions Inc
12 Mar 24
Intelligent Bio Solutions Announces $10.1 Million Private Placement Priced At-the-Market Under Nasdaq Rules
8:30pm
to the Holder for any issue or transfer tax or other incidental expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses … thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto. The Company shall pay all Transfer Agent fees required
8-K
EX-10.1
INBS
Intelligent Bio Solutions Inc
12 Mar 24
Intelligent Bio Solutions Announces $10.1 Million Private Placement Priced At-the-Market Under Nasdaq Rules
8:30pm
is in default with respect to any Indebtedness.
(cc) Tax Status. Except for matters that would not, individually or in the aggregate, have or reasonably … and local income and all foreign income and franchise tax returns, reports and declarations required by any jurisdiction to which it is subject, (ii) has
8-K
EX-4.4
cbiqoqe4v6p 7rcogl
12 Mar 24
Intelligent Bio Solutions Announces $10.1 Million Private Placement Priced At-the-Market Under Nasdaq Rules
8:30pm
8-K
EX-10.2
70mygk
12 Mar 24
Intelligent Bio Solutions Announces $10.1 Million Private Placement Priced At-the-Market Under Nasdaq Rules
8:30pm
8-K
EX-4.3
4cpknb9jd1tr
12 Mar 24
Intelligent Bio Solutions Announces $10.1 Million Private Placement Priced At-the-Market Under Nasdaq Rules
8:30pm
8-K
EX-10.1
i8fgrgozpr14p1 1ln
1 Mar 24
Entry into a Material Definitive Agreement
4:15pm
8-K
EX-99.1
3ljex2ve6een3s
9 Feb 24
Intelligent Bio Solutions Inc. Reports Fiscal Second Quarter and Six-Month Financial Results and Operational Highlights
5:05pm
8-K
EX-4.1
x2zm2pnif4s74nyje
7 Feb 24
Intelligent Bio Solutions Inc. Announces Exercise of Previously Issued Warrants for $1.77 Million in Gross Proceeds
5:05pm
8-K
EX-4.2
zgvqucvm1ihk
7 Feb 24
Intelligent Bio Solutions Inc. Announces Exercise of Previously Issued Warrants for $1.77 Million in Gross Proceeds
5:05pm
8-K
EX-99.1
hb0he5ke th1vx1j4eq
18 Dec 23
Other Events
4:20pm
8-K
EX-10.1
0o4zn19
14 Dec 23
Submission of Matters to a Vote of Security Holders
5:00pm
8-K
EX-99.1
7gjj82 so2fkx
8 Nov 23
Intelligent Bio Solutions Inc. Reports Fiscal 2024 First Quarter Financial Results and Operational Highlights
5:27pm